Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration

EDUARDO MUÑOZ BLANCO2026-01-292026-01-29201910.1186/s40035-019-0148-x2-s2.0-85062634624https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/30149Cellular and Molecular NeuroscienceCognitive NeuroscienceNeurology (clinical)Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegenerationresearch article